| Authors: |
Rodriguez V; Division of Pediatric Hematology/Oncology, Nationwide Children's Hospital, The Ohio State University, Columbus, OH., O'Brien SH; Division of Pediatric Hematology/Oncology, Nationwide Children's Hospital, The Ohio State University, Columbus, OH., Orgel E; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA.; Keck School of Medicine, University of Southern California, Los Angeles, CA., Schultz CL; Nemours Center for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE., Esbenshade AJ; Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN., Memaj A; Biostatistics Medical Affairs, Bristol Myers Squibb, Inc, Lawrenceville, NJ., Dyme JL; Clinical Science Program, Bristol Myers Squibb, Inc, Lawrenceville, NJ., Favatella NA; Clinical Science Program, Bristol Myers Squibb, Inc, Lawrenceville, NJ., Mitchell LG; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada. |
